Skip to content
sellModerate cluster of 2

Nicholas Donoghoe sold $2.6M of ABBV

EVP, CHIEF BUS/STRAT OFFICER at AbbVie Inc.. 13,295 shares at an average of $198.51, traded Aug 5, 2025, filed Aug 7, 2025.

Warning score
53
Value
$2.6M
13,295 shares
Holdings after
58,247
-19% from before
From 52-week low
+24%
low $155.73, close $192.58
From 52-week high
-7%
high $206.43, as of Aug 5, 2025

Score components

  • Role
    Officer
    +15
  • Trade size
    $2.6M at market
    +25
  • Share of holdings sold
    Sold 19% of holdings
    +5
  • Cluster
    2 insiders selling within 14 days
    +8

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

ABBVOct 9, 2026 · close 276.47
Since filing Aug 7, 2025: +43.3%SPY +24.8% · excess +18.5%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001415889-25-021280, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Aug 5, 2025SOpen-market sale
Common Stock, $0.01 par value
-3,234$198.27$641k68,308Aug 7, 2025
Aug 5, 2025SOpen-market sale
Common Stock, $0.01 par value
-10,061$198.59$2.0M58,247Aug 7, 2025

Related signals

Other insiders at AbbVie Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
43Moderate
ABBVsell 2
AbbVie Inc.
Azita Saleki-Gerhardt
EVP, CHIEF OPERATIONS OFFICER
$8.4M
42,370 shares
-19%
45Moderate
ABBVsell
AbbVie Inc.
Jeffrey Ryan Stewart
EVP, CHIEF COMMERCIAL OFFICER
$12M
58,832 shares
-52%
82Strong
ABBVsell 4
AbbVie Inc.
Scott T Reents
EVP, CHIEF FINANCIAL OFFICER
$3.7M
17,644 shares
-60%
40Moderate
ABBVsell 510b5-1
AbbVie Inc.
Perry C Siatis
EVP, GC AND SECRETARY
$5.8M
27,900 shares
-192%
60Notable
ABBVsell 5
AbbVie Inc.
Richard A Gonzalez
director
$20M
98,628 shares
-20%
55Moderate
ABBVsell 510b5-1
AbbVie Inc.
Timothy J. Richmond
EVP, CHIEF HR OFFICER
$4.5M
21,250 shares
-78%
40Moderate
ABBVsell 410b5-1
AbbVie Inc.
Timothy J. Richmond
EVP, CHIEF HR OFFICER
$6.1M
29,917 shares
-58%
70Notable
ABBVsell 4
AbbVie Inc.
Kevin K Buckbee
SVP, CONTROLLER
$3.9M
18,944 shares
-124%
40Moderate
ABBVsell 410b5-1
AbbVie Inc.
Perry C Siatis
EVP, GC AND SECRETARY
$1.1M
5,778 shares
-21%
19Weak
ABBVsell
AbbVie Inc.
Kevin K Buckbee
SVP, CONTROLLER
$310k
1,800 shares
-20%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Nicholas Donoghoe sold $2.6M of ABBV | InsiderTell